Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research    » Alternative Medicine    » Beta Cells    » Cause    » Cells    » Children    » Complications    » Control    » Cure    » Diagnosis    » Drugs    » Elderly    » Genes    » Immune Cells    » Inhaled Insulin    » Insulin    » Islet Cells    » Neuropathy    » Obesity    » Oral Insulin    » Other Diseases    » Pets    » Pre-Diabetes    » Prevention    » Research    » Retinopathy    » Risk Factors    » Stem Cells    » Technology    » Testing    » Transplants    » Treatments    » Trials    » Type 1    » Type 2 Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Research » Complications

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Drinking Green Tea Reduces CVD Mortality Posted: Thursday, September 28, 2006

A prospective cohort study of more than 40,000 people in Japan has shown that drinking green tea can significantly cut deaths from cardiovascular disease (CVD) as well as all-cause mortality, particularly in women.

Ibuprofen Reduces Protective Effects of Aspirin Posted: Thursday, September 28, 2006

The US Food and Drug Administration (FDA) has notified healthcare professionals and consumers that taking ibuprofen for pain relief may interfere with the benefits of aspirin taken for heart disease.

Analysis of 6 Studies Shows Aspirin Can Reduce the Risk for Coronary Heart Disease Posted: Thursday, September 28, 2006

Even with the positive results from all of the studies with over 100,000 patients, most patients with Type 2 diabetes are not taking aspirin!

Diabetes Drug Shows Promise In Treating Alzheimer's Posted: Thursday, September 21, 2006

Treatment of high blood sugar may have a scientific connection to memory loss that could, one day, benefit millions of people with Alzheimer's Disease, which affects up to 4.5 million older Americans, bringing with it impaired thinking and memory.

The Earlier You Get Diabetes, The Worse it Will Get Posted: Thursday, September 21, 2006

People who develop type 2 diabetes when they're younger than 50 years of age are more likely to experience a worsening of their disease than those diagnosed at an older age.

Optimizing Control in Diabetes (OPTIMIZE) Survey Urges Action NOW! Posted: Thursday, September 21, 2006

Diabetes experts have warned that urgent action needs to be taken to drastically improve the management of diabetes to prevent a potentially devastating and costly global burden.

Pioglitazone Demonstrates Significant Improvements in Cardiovascular Outcomes Posted: Thursday, September 21, 2006

Actos® (pioglitazone HCl), an oral antidiabetic medication, demonstrated significant cardiovascular benefits in reducing the risk of heart attack and/or stroke and acute coronary syndrome in patients with type 2 diabetes.

A Mid-Summer’s Night DREAM: Diabetes Prevention (Part 2- Ramipril Arm) Posted: Thursday, September 21, 2006

The Dream Study also found that the ACE-inhibitor Altace (ramipril) does not prevent type 2 diabetes in patients with impaired glucose metabolism.

Significant Glucose-Lowering Efficacy Of JANUVIA™ in Phase III Study Posted: Thursday, September 21, 2006

New data presented for the first time at the 42nd annual meeting of the European Association for the Study of Diabetes (EASD) in Copenhagen demonstrated a mean reduction in A1C of 2.1% from a mean baseline A1C of 8.8% and a reduction of 2.9% for those with a mean A1c of 11.2%.

Galvus® Demonstrates Powerful Blood Sugar Reductions In Phase III Studies Posted: Thursday, September 21, 2006

Galvus dropped A1c by 1.8% without weight gain.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.